In systemic T-cell NHL, diffuse expression (> 50%) was detected in 76% of the ALCL ALK negative patients, 78% of AITL and 53% ALCL ALK positive. The gene discussed is ALK; the disease is angioimmunoblastic T-cell lymphoma.